Raaj Medisafe India (BSE 524502)₹102.15+0.34%Packaging
In the Mar 2026 quarter (standalone), Raaj Medisafe India reported sales of ₹25.15 Cr, up 2.8% from Mar 2025, and net profit of −₹3.22 Cr, down 192.3% year on year. For the year to Mar 2026, sales were ₹80.25 Cr and net profit ₹1.80 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.56 | 11.24 | 10.21 | 11.40 | 10.94 | 10.96 | 14.63 | 24.47 | 15.88 | 18.46 | 20.78 | 25.15 |
| Expenses | 9.28 | 9.60 | 8.62 | 9.01 | 9.14 | 9.15 | 12.34 | 21.23 | 13.17 | 15.60 | 16.98 | 22.30 |
| Operating Profit | 1.22 | 1.58 | 1.53 | 2.33 | 1.74 | 1.74 | 2.23 | 3.12 | 2.63 | 2.76 | 3.70 | 2.72 |
| OPM % | 11.5% | 14.1% | 15.0% | 20.5% | 15.9% | 15.9% | 15.3% | 12.8% | 16.6% | 15.0% | 17.9% | 10.9% |
| Other Income | 0.00 | 0.02 | 0.00 | 0.03 | 0.00 | 0.00 | −0.02 | 0.12 | 0.00 | 0.24 | 0.03 | 0.27 |
| Interest | 0.40 | 0.34 | 0.38 | 0.48 | 0.37 | 0.37 | 0.53 | 0.69 | 0.69 | 0.83 | 1.39 | 1.09 |
| Depreciation | 0.19 | 0.19 | 0.20 | 0.22 | 0.22 | 0.22 | 0.39 | 0.43 | 0.48 | 0.42 | 0.49 | 0.62 |
| Profit before tax | 0.64 | 1.06 | 0.95 | 1.67 | 1.15 | 1.15 | 1.30 | 2.11 | 1.47 | 1.74 | 1.86 | 1.29 |
| Tax % | 0.0% | 0.0% | 0.0% | 57.9% | 15.8% | 15.9% | 19.4% | −65.2% | 0.0% | 0.0% | −2.7% | 353.2% |
| Net Profit | 0.62 | 1.07 | 0.93 | 0.71 | 0.98 | 0.96 | 1.04 | 3.49 | 1.45 | 1.74 | 1.90 | −3.22 |
| EPS (Rs) | 0.59 | 0.98 | 0.87 | 0.65 | 0.74 | 0.74 | 0.79 | 2.64 | 1.12 | 1.33 | 1.45 | −1.98 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.81 | 4.44 | 4.64 | 4.81 | 21.89 | 31.92 | 34.80 | 38.73 | 43.40 | 62.60 | 80.25 | 80.27 |
| Expenses | 2.10 | 4.48 | 5.06 | 5.56 | 20.21 | 27.67 | 29.51 | 32.87 | 36.46 | 53.64 | 68.04 | 68.05 |
| Operating Profit | −0.32 | −0.09 | −0.46 | −0.79 | 1.52 | 4.07 | 5.09 | 5.62 | 6.65 | 8.64 | 11.78 | 11.81 |
| OPM % | −17.2% | −1.8% | −9.7% | −16.2% | 7.0% | 12.8% | 14.7% | 14.6% | 15.4% | 13.9% | 14.8% | 14.7% |
| Other Income | 0.02 | 0.02 | 0.00 | 0.26 | 0.35 | 0.02 | 0.09 | 0.01 | 0.05 | 0.21 | 0.55 | 0.54 |
| Interest | 0.55 | 0.52 | 0.67 | 0.76 | 1.17 | 0.75 | 0.72 | 1.12 | 1.58 | 2.14 | 3.97 | 4.00 |
| Depreciation | 0.23 | 0.26 | 0.30 | 0.30 | 0.67 | 0.70 | 0.71 | 0.74 | 0.83 | 1.44 | 2.03 | 2.01 |
| Profit before tax | −1.09 | −0.84 | −1.43 | −1.60 | 0.02 | 2.63 | 3.74 | 3.78 | 4.30 | 5.26 | 6.33 | 6.36 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 3,100.1% | 12.3% | 19.1% | 11.7% | 22.4% | −16.5% | 71.6% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −1.09 | −0.82 | −1.42 | −1.60 | −0.30 | 2.31 | 3.00 | 3.32 | 3.34 | 6.14 | 1.80 | 1.87 |
| EPS (Rs) | −2.15 | −1.66 | −2.85 | −3.16 | −0.59 | 2.11 | 2.76 | 3.05 | 3.05 | 4.65 | 1.11 | 1.92 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.98 | 4.99 | 4.99 | 4.98 | 4.99 | 10.86 | 10.86 | 10.86 | 10.86 | 10.85 | 13.13 | 16.35 |
| Reserves | −7.94 | −9.02 | −9.88 | −11.31 | −12.90 | −12.08 | −9.82 | −6.75 | −3.41 | −0.07 | 13.68 | 30.20 |
| Borrowings | 7.10 | 7.61 | 9.03 | 9.44 | 11.61 | 11.88 | 13.13 | 13.03 | 15.61 | 25.86 | 34.51 | 64.09 |
| Other Liabilities | 0.24 | 1.65 | 1.61 | 2.06 | 1.41 | 2.90 | 2.40 | 2.44 | 2.64 | 4.50 | 7.68 | 10.37 |
| Total Liabilities | 4.38 | 5.23 | 5.75 | 5.17 | 5.11 | 13.56 | 16.57 | 19.58 | 25.70 | 41.14 | 69.00 | 121 |
| Fixed Assets | 3.29 | 3.56 | 3.48 | 3.46 | 3.47 | 7.01 | 7.25 | 9.29 | 8.61 | 10.69 | 23.02 | 38.99 |
| CWIP | 0.00 | 0.00 | 0.53 | 0.00 | 0.00 | 0.00 | 1.59 | 0.00 | 1.58 | 10.10 | 8.47 | 26.67 |
| Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Other Assets | 1.07 | 1.65 | 1.72 | 1.69 | 1.62 | 6.47 | 7.65 | 10.21 | 15.43 | 20.27 | 37.43 | 55.27 |
| Inventories | 0.06 | 0.28 | 0.86 | 0.66 | 0.56 | 0.86 | 1.51 | 3.10 | 6.60 | 8.45 | 8.13 | 14.85 |
| Trade receivables | 0.08 | 0.58 | 0.44 | 0.78 | 0.83 | 4.71 | 4.91 | 5.45 | 6.87 | 7.90 | 16.72 | 11.76 |
| Cash & equivalents | 0.40 | 0.03 | 0.02 | 0.03 | 0.03 | 0.08 | 0.02 | 0.02 | 0.04 | 0.06 | 0.05 | 13.00 |
| Total Assets | 4.38 | 5.23 | 5.75 | 5.17 | 5.11 | 13.56 | 16.57 | 19.58 | 25.70 | 41.14 | 69.00 | 121 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.17 | 0.13 | −0.22 | 0.00 | −1.36 | −1.02 | 2.22 | 2.44 | 0.16 | 4.25 | −0.08 | 3.65 |
| Cash from investing activity | −2.13 | −0.50 | −0.67 | 0.26 | −0.04 | −0.20 | −2.77 | −0.95 | −1.66 | −12.99 | −16.40 | −21.67 |
| Cash from financing activity | 2.62 | −0.01 | 0.91 | −0.25 | 1.42 | 1.23 | 0.50 | −1.46 | 1.48 | 8.71 | 16.47 | 30.86 |
| Net cash flow | 0.32 | −0.40 | 0.02 | 0.00 | 0.00 | 0.00 | −0.05 | 0.03 | −0.02 | 0.03 | 0.03 | 12.97 |
| Capex | 2.12 | 0.50 | 0.72 | 0.04 | 0.32 | 0.21 | 3.88 | 1.20 | 1.72 | 11.62 | 14.69 | 15.23 |
| Free cash flow | −2.32 | −0.38 | −0.92 | 0.26 | −1.44 | −1.26 | −0.57 | 1.32 | −1.57 | −7.38 | −13.03 | −29.88 |
| CFO / OP % | 30.0% | −45.0% | 288.0% | 2.0% | 176.0% | −68.0% | 55.0% | 48.0% | 14.0% | 74.0% | 10.0% | 31.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | 116 | 36 | 61 | 62 | 79 | 56 | 57 | 65 | 67 | 98 | 54 |
| Inventory days | 2,555 | 107 | 141 | 99 | 65 | 21 | 25 | 48 | 90 | 106 | 68 | 106 |
| Days payable | 5,474 | 537 | 233 | 274 | 132 | 51 | 18 | 6 | 10 | 8 | 35 | 35 |
| Cash conversion cycle | — | −317 | −58 | −117 | −7 | 47 | 60 | 98 | 143 | 162 | 129 | 122 |
| Working capital days | — | −57 | −88 | −141 | −124 | −8 | 9 | 5 | 36 | 22 | 10 | 10 |
| ROCE % | −23.5% | −14.1% | −9.1% | −21.0% | −32.1% | 16.4% | 27.1% | 27.9% | 24.2% | 19.5% | 15.0% | 11.9% |
For the Mar 2026 quarter, Raaj Medisafe India reported sales of ₹25.15 Cr, up 2.8% year on year and net profit of −₹3.22 Cr, down 192.3% year on year. The operating margin was 10.9%.
Raaj Medisafe India's sales for the year to Mar 2026 were ₹80.25 Cr; over the last twelve months they were ₹80.27 Cr.
Net profit for the year to Mar 2026 was ₹1.80 Cr, and ₹1.87 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.92.
Raaj Medisafe India reported borrowings of ₹64.09 Cr at Mar 2026, against cash and equivalents of ₹13 Cr.
Cash from operations was ₹3.65 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹29.88 Cr.